Free Trial

UnitedHealth Group (UNH) Competitors

UnitedHealth Group logo
$367.11 +3.24 (+0.89%)
Closing price 03:59 PM Eastern
Extended Trading
$365.10 -2.01 (-0.55%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UNH vs. ALKS, MEDP, CI, CNC, and CVS

Should you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), and CVS Health (CVS). These companies are all part of the "medical" sector.

How does UnitedHealth Group compare to Alkermes?

Alkermes (NASDAQ:ALKS) and UnitedHealth Group (NYSE:UNH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

UnitedHealth Group has higher revenue and earnings than Alkermes. Alkermes is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alkermes$1.48B3.98$241.66M$1.4324.70
UnitedHealth Group$447.57B0.74$12.06B$13.2427.73

Alkermes presently has a consensus target price of $45.21, indicating a potential upside of 28.01%. UnitedHealth Group has a consensus target price of $378.88, indicating a potential upside of 3.21%. Given Alkermes' stronger consensus rating and higher possible upside, equities analysts clearly believe Alkermes is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alkermes
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.82
UnitedHealth Group
2 Sell rating(s)
6 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.69

In the previous week, UnitedHealth Group had 61 more articles in the media than Alkermes. MarketBeat recorded 84 mentions for UnitedHealth Group and 23 mentions for Alkermes. UnitedHealth Group's average media sentiment score of 1.00 beat Alkermes' score of 0.66 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alkermes
9 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
51 Very Positive mention(s)
15 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive

95.2% of Alkermes shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 4.6% of Alkermes shares are held by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Alkermes has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Alkermes has a net margin of 9.78% compared to UnitedHealth Group's net margin of 2.68%. UnitedHealth Group's return on equity of 14.65% beat Alkermes' return on equity.

Company Net Margins Return on Equity Return on Assets
Alkermes9.78% 9.26% 5.66%
UnitedHealth Group 2.68%14.65%4.77%

Summary

Alkermes beats UnitedHealth Group on 9 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to Medpace?

Medpace (NASDAQ:MEDP) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

78.0% of Medpace shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 0.3% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Medpace has a net margin of 17.19% compared to UnitedHealth Group's net margin of 2.68%. Medpace's return on equity of 120.89% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace17.19% 120.89% 24.79%
UnitedHealth Group 2.68%14.65%4.77%

UnitedHealth Group has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B4.82$451.12M$15.9126.83
UnitedHealth Group$447.57B0.74$12.06B$13.2427.73

In the previous week, UnitedHealth Group had 43 more articles in the media than Medpace. MarketBeat recorded 84 mentions for UnitedHealth Group and 41 mentions for Medpace. UnitedHealth Group's average media sentiment score of 1.00 beat Medpace's score of 0.35 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
12 Very Positive mention(s)
1 Positive mention(s)
28 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
UnitedHealth Group
51 Very Positive mention(s)
15 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Medpace presently has a consensus price target of $467.08, indicating a potential upside of 9.44%. UnitedHealth Group has a consensus price target of $378.88, indicating a potential upside of 3.21%. Given Medpace's higher probable upside, analysts plainly believe Medpace is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
1 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.20
UnitedHealth Group
2 Sell rating(s)
6 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.69

Summary

UnitedHealth Group beats Medpace on 9 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to Cigna Group?

UnitedHealth Group (NYSE:UNH) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

UnitedHealth Group has higher revenue and earnings than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.74$12.06B$13.2427.73
Cigna Group$274.90B0.27$5.96B$23.5911.95

UnitedHealth Group has a net margin of 2.68% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group2.68% 14.65% 4.77%
Cigna Group 2.26%19.75%5.30%

UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.4%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has increased its dividend for 15 consecutive years and Cigna Group has increased its dividend for 5 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, UnitedHealth Group had 41 more articles in the media than Cigna Group. MarketBeat recorded 84 mentions for UnitedHealth Group and 43 mentions for Cigna Group. UnitedHealth Group's average media sentiment score of 1.00 beat Cigna Group's score of 0.93 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
51 Very Positive mention(s)
15 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
22 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

87.9% of UnitedHealth Group shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.3% of UnitedHealth Group shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

UnitedHealth Group has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

UnitedHealth Group presently has a consensus price target of $378.88, suggesting a potential upside of 3.21%. Cigna Group has a consensus price target of $338.35, suggesting a potential upside of 19.98%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts plainly believe Cigna Group is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
2 Sell rating(s)
6 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.69
Cigna Group
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.86

Summary

UnitedHealth Group beats Cigna Group on 12 of the 19 factors compared between the two stocks.

How does UnitedHealth Group compare to Centene?

UnitedHealth Group (NYSE:UNH) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of UnitedHealth Group shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

UnitedHealth Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$447.57B0.74$12.06B$13.2427.73
Centene$194.78B0.14-$6.67B-$13.14N/A

UnitedHealth Group currently has a consensus price target of $378.88, suggesting a potential upside of 3.21%. Centene has a consensus price target of $53.82, suggesting a potential downside of 2.67%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts plainly believe UnitedHealth Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
2 Sell rating(s)
6 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.69
Centene
2 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.21

UnitedHealth Group has a net margin of 2.68% compared to Centene's net margin of -3.25%. UnitedHealth Group's return on equity of 14.65% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group2.68% 14.65% 4.77%
Centene -3.25%5.57%1.54%

In the previous week, UnitedHealth Group had 46 more articles in the media than Centene. MarketBeat recorded 84 mentions for UnitedHealth Group and 38 mentions for Centene. UnitedHealth Group's average media sentiment score of 1.00 beat Centene's score of 0.94 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
51 Very Positive mention(s)
15 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive
Centene
18 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

UnitedHealth Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Centene has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Summary

UnitedHealth Group beats Centene on 14 of the 17 factors compared between the two stocks.

How does UnitedHealth Group compare to CVS Health?

CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 3.1%. UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.4%. CVS Health pays out 192.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. CVS Health has raised its dividend for 4 consecutive years and UnitedHealth Group has raised its dividend for 15 consecutive years.

80.7% of CVS Health shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.9% of CVS Health shares are held by company insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

UnitedHealth Group has higher revenue and earnings than CVS Health. UnitedHealth Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.28$1.77B$1.3862.96
UnitedHealth Group$447.57B0.74$12.06B$13.2427.73

CVS Health currently has a consensus price target of $94.61, suggesting a potential upside of 8.89%. UnitedHealth Group has a consensus price target of $378.88, suggesting a potential upside of 3.21%. Given CVS Health's stronger consensus rating and higher probable upside, equities analysts plainly believe CVS Health is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
4 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.83
UnitedHealth Group
2 Sell rating(s)
6 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.69

UnitedHealth Group has a net margin of 2.68% compared to CVS Health's net margin of 0.44%. UnitedHealth Group's return on equity of 14.65% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health0.44% 11.31% 3.35%
UnitedHealth Group 2.68%14.65%4.77%

In the previous week, UnitedHealth Group had 24 more articles in the media than CVS Health. MarketBeat recorded 84 mentions for UnitedHealth Group and 60 mentions for CVS Health. UnitedHealth Group's average media sentiment score of 1.00 beat CVS Health's score of 1.00 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
36 Very Positive mention(s)
7 Positive mention(s)
11 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
51 Very Positive mention(s)
15 Positive mention(s)
3 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive

CVS Health has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Summary

UnitedHealth Group beats CVS Health on 14 of the 19 factors compared between the two stocks.

Get UnitedHealth Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupMED IndustryMedical SectorNYSE Exchange
Market Cap$330.47B$47.05B$6.28B$22.97B
Dividend Yield2.43%1.92%2.77%4.03%
P/E Ratio27.7323.2924.8425.50
Price / Sales0.740.61491.7724.82
Price / Cash17.1122.0543.4225.32
Price / Book3.212.529.844.65
Net Income$12.06B$1.46B$3.55B$1.07B
7 Day Performance-0.87%0.68%3.90%2.66%
1 Month Performance30.43%19.29%6.04%7.00%
1 Year Performance-7.11%-17.61%40.49%32.62%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UNH
UnitedHealth Group
4.1539 of 5 stars
$367.11
+0.9%
$378.88
+3.2%
-10.1%$330.47B$447.57B27.73390,000
ALKS
Alkermes
3.6501 of 5 stars
$33.72
+0.0%
$44.07
+30.7%
+15.4%$5.61B$1.48B23.582,050
MEDP
Medpace
3.1452 of 5 stars
$418.53
+1.2%
$467.08
+11.6%
+43.2%$11.95B$2.68B26.316,200
CI
Cigna Group
4.9382 of 5 stars
$290.58
-0.6%
$332.47
+14.4%
-17.2%$76.58B$274.88B13.1067,700
CNC
Centene
2.9459 of 5 stars
$53.80
-0.3%
$51.41
-4.4%
-11.4%$26.46B$194.78BN/A61,100

Related Companies and Tools


This page (NYSE:UNH) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners